• 南宫NG·28(中国)相信品牌力量有限公司

    Apeloa
    南宫28药业
    DP Technology Platforms
    Controlled-release Formulation Development Taste Masking Technology Particle Flow Simulation
    Controlled-release Formulation Development Platform
    Controlled-release formulations control the action of drugs by regulating the rate and duration of drug release, thereby reducing dosing frequency and enhancing the safety, efficacy, reliability, and convenience of drug therapy, ultimately improving patient compliance. With the improvement of economic levels and the development of the pharmaceutical industry, the importance of controlled-release drug technology continues to increase. The construction of controlled-release formulation technology platforms will continuously enable the company to develop high technological barriers for controlled-release products, providing ample technical support for future market competition.
    南宫28药业
    Research Fields
    南宫28药业
    Pellet sustained and controlled release technology
    Film controlled coating technology
    Hydrophilic gel matrix sustained-release tablets
    Insoluble matrix sustained-release tablets
    Selected Projects
    南宫28药业
    Metoprolol succinate sustained-release tablets: sustained-release pellets, pellet compressed tablets Bupropion Hydrochloride Sustained Release Tablets, APF2003: Controlled Coating Technology AF22207, AF23204: Hydrophilic gel matrix sustained-release tablets AF23216: Insoluble matrix sustained-release tablets
    南宫28药业
    南宫28药业
    南宫28药业
    南宫28药业